Tolerability and Persistence with Subcutaneous Immunoglobulin Provided Through Physician Clinics for the Treatment of Primary Immunodeficiencies

Presented on February 22, 2019

Authors:
Richard F. Herrscher, MD, FACAAI – AIRCare, Dallas, TX
Tidence L. Prince, MD – The Allergy Asthma and Sinus Center, Knoxville
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Sugar Land, TX

View Poster